Related Experiment Video
Updated: Jan 11, 2026

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
Serum Fourier-Transform Infrared Spectroscopy with Machine Learning for Screening of Pediatric Acute Lymphoblastic
Aneta Kowal1, Paweł Jakubczyk2, Wioletta Bal3,4
1Doctoral School, Institute of Medical Science, University of Rzeszów, 35-959 Rzeszów, Poland.
Fourier-transform infrared (FTIR) spectroscopy shows promise for detecting pediatric acute lymphoblastic leukemia (ALL) in serum. This rapid, non-invasive method could offer a cost-effective diagnostic alternative to bone marrow biopsies.
Area of Science:
- Biochemistry
- Medical Diagnostics
- Spectroscopy
Background:
- Acute lymphoblastic leukemia (ALL) is the most common childhood cancer.
- Current diagnostic methods, such as bone marrow procedures, are invasive and costly.
- There is a need for non-invasive, rapid, and cost-effective diagnostic tools for pediatric ALL.
Purpose of the Study:
- To investigate the potential of Fourier-transform infrared (FTIR) spectroscopy for diagnosing pediatric ALL.
- To identify spectral differences in serum between ALL patients and healthy controls.
- To assess the diagnostic performance of FTIR spectroscopy in distinguishing ALL from controls.
Main Methods:
- Serum samples from 103 participants (45 ALL patients, 58 controls) were analyzed using FTIR spectroscopy.
- Spectra were preprocessed, and statistical analyses, including logistic regression and cross-validation, were performed.
- Receiver operating characteristic (ROC) and precision-recall (PR) analyses were conducted to evaluate performance.
Main Results:
- Distinct spectral alterations were observed between ALL patients and controls, particularly in amide and lipid regions.
- Logistic regression achieved an area under the curve (AUC) of approximately 0.80, with sensitivity ranging from 0.73-0.84.
- Principal component analysis (PCA) and hierarchical cluster analysis (HCA) showed partial but consistent group separation.
Conclusions:
- Serum FTIR spectroscopy demonstrates potential for distinguishing pediatric ALL from controls.
- The technique reflects disease-related metabolic changes and is rapid, label-free, and requires minimal serum.
- Further validation in larger, multi-center studies is necessary before clinical implementation.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013